Novadaq Technologies Inc.TSX: NDQ

Novadaq to hold second quarter 2005 conference call and webcast

· Issued by Novadaq Technologies Inc. via CNW
TORONTO, Aug. 5 /CNW/ - Novadaq(TM) Technologies Inc. (TSX: NDQ) today
announced that it intends to host a conference call on Friday August 12, 2005
at 10:00 a.m. E.T. to discuss its financial results for the second quarter
ended June 30, 2005. The Company intends to disclose its financial results via
news release on August 12, 2005 before market open.
To access the conference call by telephone, dial 1-800-240-5318. Please
connect approximately ten minutes prior to the beginning of the call to ensure
participation. The conference call will be archived for replay until     
August 19, 2005 at midnight. To access the archived conference call, dial   
416-640-1917 or 1-877-289-8525 enter the reservation number 21132810 followed
by the number sign.
A live audio webcast of the conference call will be available at
www.novadaq.com. Please connect at least ten minutes prior to the conference
call to ensure adequate time for any software download that may be required to
join the webcast. The webcast will be archived at the above website for
90 days.

About Novadaq Technologies
Novadaq(TM) Technologies (TSX: NDQ) develops and commercializes medical
devices based on its proprietary imaging platform for the diagnosis and
treatment of human vascular and ophthalmic diseases and conditions. Novadaq's
SPY(TM) Intra-operative System enables surgeons to visually assess coronary
vasculature and bypass graft functionality during the course of CABG surgery.
Novadaq's ophthalmic product, OPTTX(TM) System, is aimed at the diagnosis,
evaluation and treatment of Wet Age Related Macular Degeneration (AMD) by
using the same core imaging technology that is used in the SPY. The OPTTX
System is currently being evaluated in clinical trials.
For more information, please visit the company's website at
www.novadaq.com.

Certain statements included in this press release may be considered
forward-looking. Such statements involve known and unknown risks,
uncertainties and other factors that may cause actual results, performance or
achievements to be materially different from those implied by such statements,
and therefore these statements should not be read as guarantees of future
performance or results. All forward-looking statements are based on Novadaq's
current beliefs as well as assumptions made by and information currently
available to Novadaq and relate to, among other things, anticipated financial
performance, business prospects, strategies, regulatory developments, market
acceptance and future commitments. Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of the date
of this press release. Due to risks and uncertainties, including the risks and
uncertainties identified by Novadaq in its public securities filings; actual
events may differ materially from current expectations. Novadaq disclaims any
intention or obligation to update or revise any forward-looking statements,
whether as a result of new information, future events or otherwise.

%SEDAR: 00022069E

Novadaq Technologies Inc. on 6ix

Earlier from Novadaq Technologies

Later from Novadaq Technologies

All Novadaq Technologies news releases